Literature DB >> 23319095

Use of quetiapine to manage patients who experienced adverse effects with clozapine.

Michael J Reinstein1, John G Sonnenberg, Sangarapillai C Mohan, Maxim A Chasanov, Lynne E Jones.   

Abstract

Entities:  

Year:  2003        PMID: 23319095     DOI: 10.2165/00044011-200323010-00008

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  18 in total

1.  Patient satisfaction with, and acceptability of, atypical antipsychotics.

Authors:  A Kalali
Journal:  Curr Med Res Opin       Date:  1999       Impact factor: 2.580

2.  Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.

Authors:  B J McConville; L A Arvanitis; P T Thyrum; C Yeh; L A Wilkinson; R O Chaney; K D Foster; M T Sorter; L M Friedman; K L Brown; J E Heubi
Journal:  J Clin Psychiatry       Date:  2000-04       Impact factor: 4.384

3.  A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group.

Authors:  R A Emsley; J Raniwalla; P J Bailey; A M Jones
Journal:  Int Clin Psychopharmacol       Date:  2000-05       Impact factor: 1.659

4.  Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.

Authors:  J G Small; S R Hirsch; L A Arvanitis; B G Miller; C G Link
Journal:  Arch Gen Psychiatry       Date:  1997-06

5.  Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.

Authors:  D Q McManus; L A Arvanitis; B B Kowalcyk
Journal:  J Clin Psychiatry       Date:  1999-05       Impact factor: 4.384

6.  The long-term effect of quetiapine (Seroquel TM ) monotherapy on weight in patients with schizophrenia.

Authors:  M Brecher; I W Rak; K Melvin; A M Jones
Journal:  Int J Psychiatry Clin Pract       Date:  2000       Impact factor: 1.812

Review 7.  Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials.

Authors:  S M Stahl
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

Review 8.  Atypical antipsychotic agents: a critical review.

Authors:  J A Worrel; P A Marken; S E Beckman; V L Ruehter
Journal:  Am J Health Syst Pharm       Date:  2000-02-01       Impact factor: 2.637

9.  A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia.

Authors:  J Peuskens; C G Link
Journal:  Acta Psychiatr Scand       Date:  1997-10       Impact factor: 6.392

Review 10.  Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy.

Authors:  J S Markowitz; C S Brown; T R Moore
Journal:  Ann Pharmacother       Date:  1999-01       Impact factor: 3.154

View more
  1 in total

Review 1.  [Augmenting atypical antipsychotic medications with clozapin].

Authors:  M Zink; H Dressing
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.